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Summary
Objective: The processes underlying sudden unexpected death in epilepsy (SUDEP) 
remain elusive, but centrally mediated cardiovascular or respiratory collapse is sus-
pected. Volume changes in brain areas mediating recovery from extreme cardiores-
piratory challenges may indicate failure mechanisms and allow prospective 
identification of SUDEP risk.
Methods: We retrospectively imaged SUDEP cases (n = 25), patients comparable 
for age, sex, epilepsy syndrome, localization, and disease duration who were high- 
risk (n = 25) or low- risk (n = 23), and age- and sex- matched healthy controls 
(n = 25) with identical high- resolution T1- weighted scans. Regional gray matter vol-
ume, determined by voxel- based morphometry, and segmentation- derived structure 
sizes were compared across groups, controlling for total intracranial volume, age, 
and sex.
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1 |  INTRODUCTION
The processes underlying sudden unexpected death in epilepsy 
(SUDEP) remain elusive. Circumstances surrounding the fatal 
event suggest a centrally mediated cardiovascular or respira-
tory collapse following a generalized tonic– clonic seizure 
(GTCS).1 Because SUDEP is the leading cause of premature 
death among people with epilepsy,2 efforts to noninvasively 
characterize potential underlying neural mechanisms mediat-
ing SUDEP and highlight imaging biomarkers are essential.
Brain structural imaging studies of SUDEP have revealed 
volume changes among key structures involved in auto-
nomic and respiratory regulation in people who succumbed 
to SUDEP and those at high risk.3 Individuals with frequent 
GTCSs, who are at highest risk of SUDEP,4 exhibit cortical 
thickness changes in key areas that are autonomic, somato-
sensory, and breathing coordination sites.5 Less attention has 
been directed to structures essential for recovery from com-
promised breathing or cardiovascular circumstances.
Regional brain volume assessments in patients who succumb 
may allow determination of processes that contribute to the fatal 
event or fail to provide adequate compensatory recovery. Those 
assessments may prospectively and noninvasively identify bio-
markers for individuals at risk and were the objectives of this study.
2 |  MATERIALS AND METHODS
2.1 | Subjects
Twenty- five individuals who suffered definite (n = 12) or prob-
able (n = 13) SUDEP6 were retrospectively identified after up-
dating an earlier initial search.3 Living high- risk (n = 25) and 
low- risk (n = 23) patients and healthy controls (n = 25) were 
identified similarly (Table 1 for group characteristics). Patients 
at high risk of SUDEP were those experiencing more than three 
GTCSs per year, the most significant factor associated with 
SUDEP,4 and distinguished >80% of SUDEP cases (21/25) 
in our data. Low- risk patients were those who did not experi-
ence GTCSs. All clinical information used for risk stratifica-
tion was obtained from multidisciplinary team meeting reports 
and clinic letters closest to data collection and confirmed with 
the most- recent follow- up. Survival of all non- SUDEP subjects 
Results: Substantial bilateral gray matter loss appeared in SUDEP cases in the medial and 
lateral cerebellum. This was less prominent in high- risk subjects and absent in low- risk 
subjects. The periaqueductal gray, left posterior and medial thalamus, left hippocampus, 
and bilateral posterior cingulate also showed volume loss in SUDEP. High- risk subjects 
showed left thalamic volume reductions to a lesser extent. Bilateral amygdala, entorhinal, 
and parahippocampal volumes increased in SUDEP and high- risk patients, with the sub-
callosal cortex enlarged in SUDEP only. Disease duration correlated negatively with para-
hippocampal volume. Volumes of the bilateral anterior insula and midbrain in SUDEP 
cases were larger the closer to SUDEP from magnetic resonance imaging.
Significance: SUDEP victims show significant tissue loss in areas essential for car-
diorespiratory recovery and enhanced volumes in areas that trigger hypotension or 
impede respiratory patterning. Those changes may shed light on SUDEP pathogene-
sis and prospectively detect patterns identifying those at risk.
K E Y W O R D S
cerebellum, limbic, magnetic resonance imaging, midbrain, sudden unexpected death in epilepsy
Key Points
• Brain volumes in cortical, subcortical, and cere-
bellar sites that influence blood pressure and 
breathing patterns are altered in SUDEP
• Volumes increased in the amygdala, entorhinal 
cortex, parahippocampal gyrus, and subcallosal 
cortex, which induce apnea or hypotension
• Volumes decreased in the cerebellum, periaque-
ductal gray, posterior cingulate, and posterior 
thalamus, sites involved in recovery from cardi-
orespiratory dysfunction
• Periaqueductal gray and posterior cingulate vol-
ume loss, and increased subcallosal volume, were 
exclusive to SUDEP
• Areas inducing apnea and hypotension may be hy-
peractive, and recovery sites may be impaired due 
to tissue loss; structural trends may aid risk 
assessment
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was confirmed through examination of clinical records. All scans 
were obtained within a defined period, ensuring identical imag-
ing protocols: (1) all subjects underwent the same high- resolution 
three- dimensional (3D) T1- weighted scan; and (2) individuals 
with insufficient clinical data, large brain lesions, and/or previ-
ous neurosurgery were excluded. High- and low- risk patients, 
comparable for age, sex, epilepsy syndrome, seizure focus lo-
calization, and duration, were identified to account for potential 
volume changes accompanying these factors. Each SUDEP case 
was also matched with a comparable healthy control for age and 
sex. Table 1 shows group characteristics. Table S1 outlines indi-
vidual clinical characteristics of SUDEP, high- risk, and low- risk 
patients. The study was approved by the UK National Research 
Ethics Committee under an ongoing database research project 
on autonomic and imaging biomarkers of SUDEP (04/Q0512/77 
and 14/SW/0021) and a local audit on mortality in epilepsy.
2.2 | Magnetic resonance imaging 
acquisition
Scanning was performed at the Epilepsy Society (Chalfont St 
Peter, Buckinghamshire, UK) on a 3.0- Tesla Signa HDx (GE 
Medical Systems) scanner, using standard imaging gradients 
(maximum strength = 40 mT/m, slew rate = 150 T/m/s). All 
subjects underwent the same fast spoiled gradient- echo 3D 
T1 scan (repetition time = 8.3 milliseconds, echo time = 3.1 
milliseconds, slices = 170, slice thickness = 1.1 mm, matrix 
size = 256 × 256, field- of- view = 240 × 240 mm).
2.3 | Voxel- based morphometry
Voxel- based morphometry (VBM) was implemented with 
the computational anatomy toolbox (CAT12),7 using SPM12 
(Statistical Parametric Mapping; http://www.fil.ion.ucl.ac.uk/
spm) and MATLAB 2017b (MathWorks), to explore gray mat-
ter (GM) volume differences across the whole brain between 
groups. Images were denoised using the spatial- adaptive non-
local means filter and normalized to MNI152 template space, 
before being segmented into GM, white matter (WM), and 
cerebrospinal fluid (CSF) classes. Modulated images were 
then smoothed with an 8- mm full- width- at- half- maximum 
Gaussian kernel and entered into a full- factorial model, with 
group as factor, and age and sex as covariates. An absolute 
threshold mask of probability = 0.2 was applied to account for 
T A B L E  1  Group characteristics of SUDEP cases, high- risk patients, low- risk patients, and HC
Characteristics SUDEP, n = 25 High risk, n = 25 Low risk, n = 23 HC, n = 25
Age, y, mean ± SD 34.4 ± 13.5 32 ± 7.5 30 ± 8.1 38 ± 12.1
Gender, M:F 18:07 18:07 16:07 18:07
Disease duration, y, mean ± SD 22.8 ± 14.2 21.4 ± 8.6 16.6 ± 9.9 N.A.
GTCSs/mo, past 12 mo, mean ± SD 2.7 ± 2.5 2.5 ± 1.5 N.A. N.A.
Focal: generalized epilepsy 22:03 22:03 19:14 N.A.
AEDs ATOS, n, mean ± SD 2.2 ± 0.8 2.7 ± 1.1 2.1 ± 0.9 N.A.
AEDs historic, n, mean ± SD 4.8 ± 3.2 8.4 ± 3.2 3.4 ± 2.8 N.A.
Exposed to phenytoin, n 5 8 3 N.A.
Long- term phenytoin users, 
>10 years, n
2 3 0 N.A.
Polytherapy, n 10 15 8 N.A.
Duotherapy, n 10 6 9 N.A.
Monotherapy, n 5 4 6 N.A.
Seizure onset zone
L temporal, HS 1 2 1 N.A.
L temporal, no HS 1 1 1 N.A.
R temporal, HS 0 1 0 N.A.
R temporal, no HS 2 1 2 N.A.
Frontal 6 5 6 N.A.
Temporal+ 7 6 2 N.A.
Generalized 3 3 4 N.A.
Posterior head regions 2 1 2 N.A.
Focal, unknown 3 3 5 N.A.
AED, antiepileptic drug; ATOS, at time of scan; F, female; GTCS, generalized tonic– clonic seizure; HC, healthy controls; HS, hippocampal sclerosis; L, left; M, male; 
N.A., not applicable; R, right; SD, standard deviation; SUDEP, sudden unexpected death in epilepsy.
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edge effects between different tissue types. Total intracranial 
volume (TIV; the sum of WM, GM, and CSF) was used to pro-
portionally scale the data to account for differences in whole 
brain size across subjects, and results were familywise error 
rate corrected at P < 0.05, unless otherwise stated.
2.4 | Regional structure parcellation using 
geodesic information flows
2.4.1 | Parcellation method
For validation and determination of difference magnitudes, 
structures showing significantly increased or reduced volume 
using VBM were segmented in each subject using a whole- 
brain parcellation scheme based on geodesic information 
flows.8 Regional brain volumes were obtained by extracting 
areas of interest from the parcellation and multiplying the 
number of voxels in each area by the voxel volume.
2.4.2 | Statistical analysis
Permutation t tests were employed to assess structural dif-
ferences between groups; for each contrast, members from 
each group were randomly permuted (10 000 times) to 
obtain an empirical null distribution. P values were cor-
rected for multiple comparisons using the false discovery 
rate (FDR). Data were initially scaled by total intracranial 
volume, and adjusted for age and sex using linear regres-
sion. All processes were carried out in MATLAB 2017b.
2.4.3 | Correlations: brain volume and 
clinical variables
Partial correlations (IBM SPSS 25) examined whether struc-
tural sizes from whole- brain parcellation depended on disease 
duration or GTCS frequency, controlling for age, sex, and TIV. 
Correlations with GTCS frequency were considered in two 
ways. We first examined correlations with SUDEP and high- 
risk subjects as one group. We then correlated volume with 
GTCS frequency in SUDEP and high- risk groups separately.
Further partial correlations assessed relationships between 
structural size and the time between magnetic resonance imag-
ing (MRI) and SUDEP, controlling for disease duration, seizure 
frequency, age, sex, and TIV. P  values were FDR- corrected.
2.5 | Contributions to tissue loss from 
medications
Several antiepileptic drugs (AEDs) induce structural changes 
via toxic processes. Medications in all patients were docu-
mented and summarized by group in Table S1. We compared 
the number of AEDs used at scan time, and the total number 
of AEDs tried across groups with nonparametric tests (IBM 
SPSS 25). Additionally, we repeated all volumetry analyses 
having removed individuals with known phenytoin exposure 
(n = 5 SUDEP, n = 8 high risk, n = 3 low risk) due to known 
cerebellar atrophy related to its use.9
3 |  RESULTS
3.1 | Cerebellar volume loss
Compared with healthy controls (Figure 1A) and low- risk 
subjects (Figure S1A), SUDEP showed major bilateral 
volume loss of the cerebellum, across medial, lateral, and 
vermal portions (VBM). High- risk subjects also showed 
reduced GM volume compared with healthy controls, but 
in the vermis only (Figure S2A). Subanalyses, removing 
those with a history of phenytoin use, revealed similar but 
less extensive patterns of cerebellar volume loss (particu-
larly in lateral portions) in SUDEP and high- risk subjects 
versus healthy controls (Figure S3A,B); no other results 
changed significantly as a consequence of removing these 
subjects. Regional segmentation comparisons revealed 
reduced volumes of the bilateral exterior cerebellar GM 
in SUDEP versus healthy controls (Figures 1 and 2B,C). 
High- and low- risk groups did not show reduced volume of 
segmented cerebellar structures.
3.2 | Thalamic and limbic alterations
The left posterior and medial thalamus and posterior hip-
pocampus exhibited reduced GM volume in SUDEP (Figure 
1B,C) and high- risk subjects (Figure S2A) versus healthy 
controls (VBM). Additionally, SUDEP but not high- risk 
subjects showed volume loss in these areas when compared 
with low- risk subjects (Figure S1A). VBM also revealed 
periaqueductal gray (PAG) and bilateral posterior cingulate 
GM volume loss in SUDEP versus healthy controls (Figure 
1B,C). Regional segmentation analysis showed the left tha-
lamic parcel was smaller in SUDEP versus healthy controls 
(Figures 1C and 2A).
The bilateral amygdala, entorhinal cortex, parahippo-
campal gyrus, and subcallosal cortex showed increased 
GM volume in SUDEP versus healthy controls (regional 
segmentation and VBM; Figures 2E- L and 3, respec-
tively). Regional segmentation analysis also revealed that 
all of these structures were larger in SUDEP versus low- 
risk patients (Figure 2E- L). High- risk patients showed 
increased right amygdala GM volume versus healthy con-
trols, using VBM (Figure S2C), and regional segmentation 
analysis showed increased bilateral amygdala and parahip-
pocampal gyrus volume (vs healthy controls and low- risk 
patients; Figure 2E- H) and entorhinal cortex volume (vs 
healthy controls only; Figure 2I- J). Compared with low- 
risk patients, both high- risk and SUDEP groups manifested 
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increased right amygdala GM using VBM (P < 0.001 un-
corrected; Figure S1B,C).
3.3 | Correlational analyses
Significant partial correlations appeared between dis-
ease duration and left (r = −0.325, P = 0.008) and right 
(r = −0.318, P = 0.009) parahippocampal gyrus size. 
Significant partial correlations also appeared between time 
to SUDEP from MRI in the left (r = −0.4, P = 0.03) and 
right (r = −0.55, P = 0.006) anterior insula (Figure 4A,B) 
and the left (r = −0.38, P = 0.04) and right (r = −0.47, 
P = 0.013) midbrain (Figure 4C,D).
GTCS frequency correlated positively with the right poste-
rior cingulate (r = 0.37, P = 0.005) and bilateral anterior cin-
gulate (left: r = 0.28, P = 0.029; right: r = 0.26, P = 0.039) 
volume, when SUDEP and high- risk subjects were analyzed 
in the same group (n = 50). When considered separately, 
high- risk patients (n = 25) showed positive correlations with 
the bilateral anterior cingulate (left: r = 0.40, P = 0.036; 
right: r = 0.55, P = 0.005), but insignificant correlations with 
the right posterior cingulate (r = 0.35, P = 0.057). When 
analyzed alone, SUDEP cases (n = 25) showed positive cor-
relations with the right hippocampus (r = 0.54, P = 0.006), 
but right posterior cingulate correlations were not significant 
(r = 0.35, P = 0.063). Negative correlations emerged with the 
left mid cingulate (r = −0.39, P = 0.042) and left anterior in-
sula (r = −0.45, P = 0.02).
3.4 | Antiepileptic medication
The number of AEDs used at scan time did not significantly 
differ across patient groups. High- risk patients had been tried 
on a significantly greater number of AEDs throughout epi-
lepsy duration versus SUDEP (t = 3.97, P < 0.001) and low- 
risk patients (t = 6.1, P < 0.001).
F I G U R E  1  Regional gray matter 
volume loss in sudden unexpected death 
in epilepsy (SUDEP) compared with 
healthy controls (HC), found in the 
bilateral cerebellum and vermis (A, B), 
periaqueductal gray (PAG; B, C), left medial 
and posterior thalamus (C), and bilateral 
posterior cingulate (B). Voxel- based 
morphometry contrast maps are overlaid 
onto a standard (MNI152) brain. The masks 
of segmented regions exhibiting reduced 
size in SUDEP < HC (P < 0.05 familywise 
error [FWE]- corrected) are overlaid in red. 
GIF, geodesic information flow
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4 |  DISCUSSION
4.1 | Summary
The most prominent outcome was a substantial loss of cer-
ebellar volume in subjects who succumbed to SUDEP and, 
to a lesser extent, those at high risk, a finding of conse-
quence to the syndrome, because the cerebellum is essential 
to recover from compromised cardiovascular and breathing 
circumstances. Other sites which maintain blood pressure in-
tegrity and project to the cerebellum—the PAG and bilateral 
posterior cingulate—also showed tissue loss; critically, these 
F I G U R E  2  Bar graphs showing group 
volume differences in the thalamus (A, 
B), exterior cerebellar gray matter (C, D), 
amygdala (E, F), parahippocampal gyrus (G, 
H), entorhinal cortex (I, J), and subcallosal 
cortex (K, L). **Significant at P < 0.05 
false discovery rate (FDR)- corrected 
compared with low- risk and healthy 
controls. *Significant at P < 0.05 FDR- 
corrected compared with healthy controls 
only. HC, healthy controls; SUDEP, sudden 
unexpected death in epilepsy
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findings were evident only in SUDEP. In addition, volume 
increases appeared in more rostral sites, which trigger apnea 
(amygdala) and hypotension (subcallosal cortex), most 
prominently in SUDEP. Many of the alterations appeared in 
comparison both to healthy controls and to patients with epi-
lepsy at low risk for SUDEP.
4.2 | Cerebellar volume loss
Extensive volume loss within the cerebellum was apparent 
in SUDEP, and to a lesser extent in high- risk patients, com-
pared with healthy controls, but not in low- risk patients. 
The cerebellum plays a major role in dampening extreme 
F I G U R E  3  Regional volume increases in sudden unexpected death in epilepsy (SUDEP) compared with healthy controls (HC), in the 
bilateral amygdala, entorhinal cortex, subcallosal cortex, and parahippocampal gyrus (B, D and F). Statistical Parametric Mapping contrast is 
overlaid in warm colors (red- yellow). Parcellation analyses (A, C, and E) show masks of segmented regions exhibiting increased size in SUDEP > 
HC (P < 0.05 familywise error [FWE]- corrected) overlaid in solid colors
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blood pressure changes,10 chemosensing, recovery from 
hypercarbia,11 and timing of upper airway and diaphragm 
action in obstructive and central apnea,12 all relevant issues 
in the circumstances surrounding SUDEP.13 Cerebellar 
volume loss occurs commonly in epilepsy and is associ-
ated with poor surgical outcome,14 chronicity,15 GTCSs,16 
and AED use.9 These issues are of major concern, because 
all, particularly poor surgical outcome17 and GTCSs,18 in-
volve cohorts at greatest risk of SUDEP. The substantial 
cerebellar tissue loss may result from excitotoxic processes 
following excessive activation of pontine or long climbing 
fibers of olivary projections. The structural impingement 
of climbing fibers on Purkinje dendrites is such that exces-
sive activation readily kills Purkinje neurons,19 a process 
well known in the neurotoxicity field, but presumably op-
erating similarly with hypoxia or ischemia from prolonged 
apnea or hypotension during ictal events. Successive ictal 
episodes accompanying chronic GTCSs would lead to 
repetitive apneic periods or rapid declines in blood pres-
sure, establishing a scenario for Purkinje cell death. The 
damaged Purkinje cells cannot effectively control the deep 
fastigial “autonomic” and “breathing” nuclei, reducing the 
potential for recovery from hypotension or apnea. Profound 
hypotension often accompanies ictal events in GTCSs20,21; 
an inability to recover from such blood pressure losses may 
lead to SUDEP.22
4.3 | Cerebellar volume loss: breathing 
implications
The cerebellum is instrumental in recovery from compro-
mised breathing circumstances.23 Cerebellar somatomotor 
coordination is essential for timely dilation of the upper air-
way ahead of descent of the diaphragm; such coordination 
F I G U R E  4  Correlations between brain volumes and disease duration across all epilepsy subjects (A, B) and time from magnetic resonance 
imaging (MRI) to sudden unexpected death in epilepsy (SUDEP) in SUDEP cases only (C- F). *Significant at P < 0.05 (false discovery rate [FDR]- 
corrected). Covariates were seizure frequency, age, sex, and total intracranial volume (and disease duration for C and D)
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prevents airway collapse in obstructive apnea. This coordina-
tion is sometimes lost in syndromes with cerebellar injury 
and compromised breathing such as heart failure, as dem-
onstrated by out- of- phase cerebellar functional MRI signals 
in response to breathing challenges24; cerebellar injury ac-
companies heart failure. Cerebellar participation is needed 
to restore breathing from sustained central apnea; the deep 
cerebellar nuclei contain chemosensitive neurons to assist re-
covery from increased hypercarbia.
4.4 | Descending influences from 
damaged structures
Altered structures in anterior areas have the potential to ex-
aggerate those descending influences on cardiorespiratory 
areas, or in other areas with tissue loss, reduce influences. 
Volume loss appeared in the PAG and bilateral posterior 
cingulate in SUDEP, as well as the left posterior thalamus 
and hippocampus in both SUDEP and high- risk groups; the 
latter finding has been described earlier,3 with the posterior 
thalamic damage presumably contributing to failure to sense 
low oxygen and hypercapnia25; dysfunctional responses to 
hypercapnia25 are pronounced in the left posterior thalamus 
in congenital central hypoventilation syndrome. The PAG re-
ceives direct projections from the amygdala central nucleus.26 
Both the PAG and posterior cingulate assist respiratory and 
cardiovascular regulation, showing single neuron discharge 
related to both breathing and cardiac timing.27 PAG volume 
loss has been shown earlier in SUDEP.28
Hippocampal tissue loss is common in epilepsy, and as 
with cerebellar Purkinje neurons, likely results from excito-
toxic processes, in the hippocampal case presumably from 
overexcitation of Schaffer collaterals (axonal collaterals from 
CA3 pyramidal cells that project to the CA1 of hippocam-
pus). These projections are glutamatergic (ie, excitatory), 
with the potential for cell destruction with exaggerated 
hypoxia- induced activation.
The ventrolateral PAG can elicit substantial increases in 
sustained (ie, “freezing”) muscle tone via the lateral vermis 
of the cerebellum, a source of concern when attempting to 
initiate cyclic breathing during an ictal event.29 Deficient car-
diorespiratory compensatory mechanisms mediated by the 
PAG have been shown to contribute to SUDEP in mice.30
Volume loss of PAG, posterior cingulate, left posterior 
thalamus, and hippocampus raises the possibility that com-
promised excitatory or timing signals from descending influ-
ences on the cerebellum may further blunt central breathing 
control.
4.5 | Anterior limbic volume increases
The increased amygdala volume is relevant because of its 
marked influences on breathing; stimulation elicits apnea 
in human epilepsy31 and triggering of respiratory phase 
changes in animal models.32 Similar amygdala volume in-
creases have been described in SUDEP3 and in the common 
epilepsies.33 Volume increases may result from multiple 
processes, including enhanced activation from experience34 
and inflammatory processes.35 Increased bilateral amygdala 
and hippocampus volume is observed in a subtype of sub-
jects with mesial temporal lobe epilepsy36; these subjects 
also have the poorest surgical outcome and are at greatest 
risk of SUDEP.17 Increased amygdala volume may reflect 
a heightened propensity for processes leading to apnea, 
which if not corrected by cerebellar recovery sites due to 
volume loss could result in an increased potential for a fatal 
outcome.
A potential explanation, and notable limitation of this 
study, is that the elevated medial temporal volume may re-
sult from tissue sagging from brain atrophy, particularly in 
the posterior fossa, which can cause tissue accumulation in 
the medial fossa. Future studies evaluating epilepsy cohorts, 
particularly those involving subjects with chronic epilepsy, 
should take this possibility into account.
The subcallosal cortex was enlarged only in SUDEP, and 
represents a significant concern if enhanced volumes indicate 
increased influences; electrical stimulation of the structure 
results in profound hypotension.22 As with amygdala influ-
ences, the combination of ineffectual cerebellar dampening 
of hypotension with enhanced subcallosal- elicited blood 
pressure declines could be catastrophic.
4.6 | Antiepileptic drugs
Cerebellar atrophy in patients with epilepsy following use 
of particular AEDs, such as phenytoin, is well described.9 
We documented medication history of all patients, includ-
ing exposure to phenytoin. The number of patients with 
phenytoin exposure in the SUDEP, high- risk, and low- risk 
groups was five, eight, and three, respectively, with only 
two SUDEP and three high- risk patients having long- term 
use (>10 years). Subanalyses of the SUDEP and high- risk 
groups, with removal of those with phenytoin exposure 
(and controlling for phenytoin use as a binary covariate), 
showed similar patterns of cerebellar volume loss to those 
groups before removal, although reduced in extent (particu-
larly in lateral cerebellar areas; Figure 4), suggesting that 
tissue loss here, specifically in the vermis, a region particu-
larly important in blood pressure control, cannot be solely 
attributed to phenytoin use. Notably, removing these sub-
jects did not significantly alter other findings of increased 
or decreased volume. Across groups, the number of AEDs 
in the treatment regimen of patients at scan time did not 
significantly differ. However, high- risk patients had, on av-
erage, tried a number of AEDs throughout their epilepsy du-
ration that was significantly greater than for SUDEP cases 
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and low- risk patients. No significant differences between 
SUDEP and low- risk patients appeared with total number 
of AEDs historically trialed. Although high- risk subjects 
and SUDEP cases had historically tried a greater number of 
AEDs compared with low- risk subjects, there is currently 
little evidence to suggest that any individual AED or com-
bination of AEDs is responsible for SUDEP or a significant 
elevation in risk. Specifically, lamotrigine is not associated 
with increased SUDEP risk, as was previously thought, and 
the number of AEDs used is not an independent SUDEP 
risk factor.37 Rather, additional AEDs reduce the risk of 
SUDEP in drug- refractory patients.38 It should, however, 
be noted that the precise role of AEDs in SUDEP risk is not 
entirely clear, and studies exploring this aspect are needed. 
In summary, the role of seizures or AED use in cerebel-
lar atrophy in epilepsy remains unclear, despite evidence 
for both.9,39 However, either scenario is concerning, given 
the cerebellum's vital roles and the major volume loss in 
SUDEP. Medication- induced injury remains an important 
consideration for epilepsy imaging studies.
4.7 | Correlational analyses with 
clinical variables
Reduced parahippocampal volume correlated with disease 
duration across all epilepsy subjects. Progressive atrophy of 
mesial temporal structures occurs in temporal lobe epilepsy,40 
and reduced volume of subcortical structures, including the 
parahippocampal gyri, is associated with greater disease du-
ration in the common epilepsies.33 Our data reinforce an as-
sociation between reduced subcortical volume and disease 
duration. It should, however, be noted that, being a cross- 
sectional design, the current study did not assess progressive 
changes in structural volumes due to lack of follow- up scans 
in many subjects. Progressive changes could be assessed 
with longitudinal imaging studies, which may elucidate the 
evolution of volumetric alterations and their association with 
SUDEP risk, a future objective of imaging research into epi-
lepsy and SUDEP.
Bilateral anterior insula and midbrain volumes correlated 
negatively (P < 0.05 FDR- corrected) with time to SUDEP 
from MRI, meaning volumes were increased the closer to 
SUDEP from scan time. This suggests that progressive en-
largement of certain structures may accompany processes 
leading to SUDEP, although this would need to be assessed 
with longitudinal imaging studies.
4.8 | Generalized tonic− clonic seizures
Because both people at high risk and cases of SUDEP ex-
perience GTCSs, a key aim of imaging studies is to out-
line their association with regional volume and consider 
any changes in relation to group comparisons with people 
not experiencing GTCSs (healthy controls and people at 
low risk). We assessed the association between GTCSs 
and regional volumes by performing correlational analy-
ses. If regional increases or decreases in volume resulted 
from GTCSs, significant correlations between GTCS fre-
quency and volume changes should occur. However, cor-
relation analyses with GTCS frequency and the size of 
structures that showed group differences (ie, the reduced 
cerebellar, vermal, and thalamic volume, or the increased 
amygdala, entorhinal, parahippocampal, or subcallosal 
volume) were not strong or significant in SUDEP or high 
risk. One structure that showed a significant group dif-
ference (SUDEP < healthy control), the right posterior 
cingulate, showed a weak significant positive correlation 
with GTCS frequency (only when SUDEP and high- risk 
subjects were considered in the same group). However, 
because this was a positive correlation, it may not offer 
insight into the volume loss of this structure observed in 
SUDEP. Significant positive correlations between GTCS 
frequency and volume were also observed for the bilat-
eral anterior cingulate, when combining both SUDEP and 
high- risk subjects in one group. Cortical thickening of the 
cingulate has recently been demonstrated in GTCS pa-
tients.5 Volume elevations associated with gliosis result-
ing from hyperexcitability due to repeated seizures may 
be operating,41 and may be indicative of limbic network 
dysfunction linked to GTCSs.42
When the high- risk and SUDEP groups were consid-
ered separately, correlations between the right posterior 
cingulate volume and GTCS frequency became nonsig-
nificant in both groups, and the finding of increased an-
terior cingulate volume with increased GTCS frequency 
remained the same in high- risk patients but became non-
significant in SUDEP. In SUDEP cases only, additional 
significant correlations between volume and GTCS fre-
quency emerged, including a positive correlation with the 
right hippocampus and negative correlations with the left 
mid cingulate and left anterior insula. These findings sug-
gest that brain volumetric processes related to elevated 
GTCS frequency may be manifested differently in high- 
risk and SUDEP subjects.
Finally, a critical difference between the high- risk and 
SUDEP groups (which had very similar GTCS frequen-
cies) was volume loss in the PAG and posterior cingulate, 
and increased volume of the subcallosal cortex, which was 
evident only in SUDEP. If specific to GTCSs, such vol-
ume alterations would be expected in high- risk subjects 
as well, but this was not the case, suggesting that these 
alterations may be separate from processes determining 
GTCS frequency. GTCS will remain a critical issue in all 
studies investigating SUDEP, especially imaging ones, 
and efforts to take this into account should be made in any 
future studies.
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4.9 | Stratification of living subjects into 
high and low risk
Living high- and low- risk patients were classified based on 
experience and frequency of GTCSs. High- risk subjects were 
those experiencing more than three GTCSs per year. Although 
risk stratification is difficult, we based our classification on the 
leading SUDEP risk factor, which also distinguished >80% of 
SUDEP cases here. The only variable to distinguish a greater 
number of SUDEP cases was presence of GTCSs, which is a 
weaker SUDEP risk factor,18 and its use to define high- risk 
would only limit interpretation of results. Although this may 
be seen as a limitation, it should also be noted that, in doing 
so, other factors known to influence volume changes, such as 
disease duration, could be partially accounted for by attempting 
to match subjects with similar attributes; thus, we were able to 
shed light not only on imaging changes related to SUDEP but 
on the greatest risk factor associated with the fatal event.
5 |  CONCLUSION
Sudden unexpected death in epilepsy is accompanied by tis-
sue changes within brain structures that trigger cardiovas-
cular and breathing collapse, and cerebellar and brainstem 
structures that are protective for recovery from such collapse. 
High- risk subjects showed alterations within similar regions, 
suggesting such features could be used to prospectively iden-
tify patients at risk. Noninvasive volumetric assessments 
within identified sites may shed light on failing mechanisms 
and represent further biomarkers of SUDEP.
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